Hu Zhou
Fujian Provincial Key Laboratory Of Innovative Drug Target Research
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Aromatic nitroolefin with inhibition efficacy in triple-negative breast cancer cells by dual targeting RXRα and tubulins.
Journal: European journal of medicinal chemistry
Published: January 07, 2025
Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: November 20, 2023
Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion.
Journal: Cell reports
Published: March 28, 2023
Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: April 01, 2020
Moving nuclear receptor Nur77 to damaged mitochondria for clearance by mitophagy.
Journal: Molecular & cellular oncology
Published: April 28, 2017
Virtual screening and experimental validation identify novel modulators of nuclear receptor RXRα from Drugbank database.
Journal: Bioorganic & medicinal chemistry letters
Published: September 01, 2016
Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression.
Journal: British journal of pharmacology
Published: April 10, 2015
NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell.
Journal: Protein & cell
Published: January 11, 2015
Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.
Journal: European journal of medicinal chemistry
Published: October 24, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026